Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation TCT 2016

Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control

Presenter: Bernard J. Gersh, Felix Mahfoud

November 01, 2016

Presentation TCT 2016

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

News Conference News TCT 2016

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Yael L. Maxwell

October 29, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

Presentation TCT 2015

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presenter: Michael A. Weber, Stephen G. Worthley, Deepak L. Bhatt

October 13, 2015

Presentation TCT 2014

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

Presenter: Donghun Shin

September 16, 2014

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Yael L. Maxwell

September 15, 2014

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

News Conference News TCT 2013

Renal Denervation Systems Show Persistent Reductions in BP

October 30, 2013

Presentation TCT 2013

TCT-81. Doppler-flow and pressure derived hyperemic microvascular resistance measurements predict abnormal H[sub]2[/sub][sup]15[/sup]O PET-quantified myocardial blood flow after...

Presenter: Guus Waard

October 29, 2013

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

Presentation TCT 2013

Renal Sympathetic Denervation - Inducing An Instantaneous And Persisting 24h Ambulatory Blood Pressure Drop In Patients With Resistant Hypertension – Results From The...

Presenter: Alexander Plehn, Sebastian Dietz, Konstantin Heinroth, Henning Lemm, Maria Leuthold, Silke Markau, Uwe Raaz, Therese Schubert, Alexander Vogt, Karl Werdan

January 31, 2013

Presentation TCT 2013

Long-term Intravascular Blood-Pressure Monitoring with a Novel, Wireless Sensor System – Results from Chronic In-vivo Studies

Presenter: Nina Cleven, Anna Woitok, Peter Isfort, Tobias Penzkofer, Michael G?rtz, Thorsten G?ttsche, Ulrich Steinseifer, Thomas Schmitz-Rode

January 31, 2013

Presentation TCT 2012

Optimizing the Diabetic Formulary: Managing the Triad of Glycemic Control, Blood Pressure, and Hyperlipidemia

Presenter: Michael Farkouh

October 26, 2012

News Conference News TCT 2012

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

October 25, 2012

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Advertisement

Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Renal Denervation Systems Show Persistent Reductions in BP

TCT-81. Doppler-flow and pressure derived hyperemic microvascular resistance measurements predict abnormal H[sub]2[/sub][sup]15[/sup]O PET-quantified myocardial blood flow after...

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Renal Sympathetic Denervation - Inducing An Instantaneous And Persisting 24h Ambulatory Blood Pressure Drop In Patients With Resistant Hypertension – Results From The...

Long-term Intravascular Blood-Pressure Monitoring with a Novel, Wireless Sensor System – Results from Chronic In-vivo Studies

Optimizing the Diabetic Formulary: Managing the Triad of Glycemic Control, Blood Pressure, and Hyperlipidemia

Transradial PCI Reduces Bleeding in High-Risk ACS Patients

More Data Needed on Renal Denervation

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content